Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating radiolabeled monoclonal antibody therapy for gastrointestinal cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: University of California, San Francisco | Conditions: Colorectal Cancer, Esophageal Cancer | Phase 1 | Status: WITHDRAWN